Evaluation of Evidence for Pathogenicity Demonstrates That BLK, KLF11, and PAX4 Should Not Be Included in Diagnostic Testing for MODY. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.2337/db21-0844
PubMed Identifier: 35108381
Publication URI: http://europepmc.org/abstract/MED/35108381
Type: Journal Article/Review
Volume: 71
Parent Publication: Diabetes
Issue: 5
ISSN: 0012-1797